Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06038409 · ClinicalTrials.gov registry record

Ketamine Treatment Plans for Chronic Conditions

A clinical trial of Chronic Pain and Anxiety Disorders, sponsored by RIVER Foundation.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT06038409 is a study of Chronic Pain and Anxiety Disorders that is actively recruiting participants, run by RIVER Foundation. The registered enrollment target is 500 participants, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06038409, a study of Chronic Pain and Anxiety Disorders, is actively recruiting participants, sponsored by RIVER Foundation.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.

Interventions

  • DRUG Ketamine

Study Locations (1)

Montana

  • RIVER Telehealth - Helena

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2023-01-01
Est. Completion 2029-06-01

Sponsor

RIVER Foundation

2 total trials

What the Registry Record Tells You About NCT06038409

The ClinicalTrials.gov registry entry for NCT06038409 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (35% lower). The listed sponsor is RIVER Foundation, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Ketamine is the first listed.

NCT06038409 reports 1 study location spanning 1 distinct geographic area - top geographies include Montana.

Frequently Asked Questions

What is clinical trial NCT06038409 about?

NCT06038409 is a clinical study titled "Ketamine Treatment Plans for Chronic Conditions". A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.

What is the current status of trial NCT06038409?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-01-01. Estimated completion is 2029-06-01.

What conditions does trial NCT06038409 study?

This clinical trial studies the following conditions: Chronic Pain, Anxiety Disorders, Chronic Disease, Depressive Disorder.

What interventions are being tested in trial NCT06038409?

The interventions under investigation include: Ketamine (DRUG).

Who is sponsoring clinical trial NCT06038409?

This trial is sponsored by RIVER Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06038409 being conducted?

This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.